Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Amazon
AMZN
|
+$529M |
| 2 |
Apple
AAPL
|
+$498M |
| 3 |
Procter & Gamble
PG
|
+$497M |
| 4 |
Elanco Animal Health
ELAN
|
+$467M |
| 5 |
AbbVie
ABBV
|
+$397M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$696M |
| 2 |
Intuit
INTU
|
+$535M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$503M |
| 4 |
Intercontinental Exchange
ICE
|
+$459M |
| 5 |
Boeing
BA
|
+$420M |
Sector Composition
| 1 | Technology | 28.58% |
| 2 | Healthcare | 18.93% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
326
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $80.9M | 0.06% |
1,759,494
-40,215
| -2% | -$1.85M |
|
327
DTE Energy
DTE
$28B
| $80.9M | 0.06% |
999,898
+209,211
| +26% | +$16.9M |
|
328
Western Digital
WDC
$32.4B
| $80.6M | 0.06% |
2,562,113
+30,743
| +1% | +$967K |
|
329
Grifois
GRFS
$6.88B
| $80.6M | 0.06% |
4,023,224
+1,662,872
| +70% | +$33.3M |
|
330
WaFd
WAFD
$2.48B
| $80.6M | 0.06% |
3,103,441
+1,030,905
| +50% | +$26.8M |
|
331
Quest Diagnostics
DGX
$20.4B
| $80.2M | 0.06% |
998,826
-88,293
| -8% | -$7.09M |
|
332
NVR
NVR
$23.6B
| $80.2M | 0.06% |
31,159
+10,275
| +49% | +$26.4M |
|
|
IGMS
333
DELISTED
IGM Biosciences
IGMS
| $79.8M | 0.06% |
1,478,805
-44,957
| -3% | -$2.43M |
|
334
Travelers Companies
TRV
$61.8B
| $79.8M | 0.05% |
803,124
-80,848
| -9% | -$8.03M |
|
335
PTC Therapeutics
PTCT
$4.52B
| $78.9M | 0.05% |
1,769,757
+283,095
| +19% | +$12.6M |
|
336
STAG Industrial
STAG
$6.84B
| $78.3M | 0.05% |
3,478,269
+471,848
| +16% | +$10.6M |
|
|
SIVB
337
DELISTED
SVB Financial Group
SIVB
| $78.1M | 0.05% |
516,863
-8,682
| -2% | -$1.31M |
|
338
Xcel Energy
XEL
$42.4B
| $77.6M | 0.05% |
1,287,577
-625,163
| -33% | -$37.7M |
|
339
Exxon Mobil
XOM
$468B
| $77.5M | 0.05% |
2,042,562
+304,484
| +18% | +$11.6M |
|
340
HealthEquity
HQY
$8.02B
| $77.2M | 0.05% |
1,526,657
-858,863
| -36% | -$43.5M |
|
341
NeoGenomics
NEO
$1.02B
| $77.2M | 0.05% |
2,794,269
-677,771
| -20% | -$18.7M |
|
342
Labcorp
LH
$23B
| $76.8M | 0.05% |
707,257
-107,105
| -13% | -$11.6M |
|
343
Advanced Micro Devices
AMD
$246B
| $76.3M | 0.05% |
1,678,388
+697,340
| +71% | +$31.7M |
|
344
Align Technology
ALGN
$9.92B
| $75.8M | 0.05% |
435,705
-106,753
| -20% | -$18.6M |
|
345
Hewlett Packard
HPE
$31B
| $75.6M | 0.05% |
7,783,839
+1,061,050
| +16% | +$10.3M |
|
346
Valero Energy
VLO
$48.9B
| $75.4M | 0.05% |
1,662,885
+494,081
| +42% | +$22.4M |
|
|
GRA
347
DELISTED
W.R. Grace & Co.
GRA
| $74.9M | 0.05% |
2,104,774
-215,519
| -9% | -$7.67M |
|
348
Rogers Corp
ROG
$1.42B
| $74.7M | 0.05% |
790,857
-391,431
| -33% | -$37M |
|
349
PNC Financial Services
PNC
$80.2B
| $74.5M | 0.05% |
777,850
+400,783
| +106% | +$38.4M |
|
|
KSU
350
DELISTED
Kansas City Southern
KSU
| $74.4M | 0.05% |
585,171
+132,830
| +29% | +$16.9M |
|